Navigation Links
FDA Psychopharmacologic Drugs Advisory Committee Recommends Approval of Alexza's ADASUVE™
Date:12/13/2011

MOUNTAIN VIEW, Calif., Dec. 13, 2011 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that the Psychopharmacologic Drugs Advisory Committee (PDAC) of the U.S. Food and Drug Administration (FDA) voted to recommend that ADASUVE™ (Staccato® loxapine) be approved for use as a single dose in 24 hours when used with the FDA recommended Risk Evaluation and Mitigation Strategy (REMS), for the treatment for agitation in patients with schizophrenia or bipolar mania.  The vote on this question was 9/8/1 (yes/no/abstain).

"We view the recommendations by the PDAC today as another step forward in the development of ADASUVE," stated Thomas B. King, President and Chief Executive Officer of Alexza Pharmaceuticals.  "We appreciate the Advisory Committee's recognition of agitation as a serious and underappreciated symptom of schizophrenia and bipolar disorder.  If approved, we believe ADASUVE represents a valuable treatment option for patients and physicians alike.  We look forward to continuing to work toward our goal of bringing ADASUVE to market in 2012."    

As previously announced, the ADASUVE NDA Prescription Drug User Fee Act (PDUFA) goal date is February 4, 2012.  In Europe, a Marketing Authorization Application (MAA) for ADASUVE is currently under review by the European Medicines Agency (EMA) and the application will follow the Centralized Procedure.

Summary of Advisory Committee Voting
The FDA takes the committee's advice into consideration as part of its review of a New Drug Application, but is not bound by an advisory committee's recommendations.  After reviewing and discussing the ADASUVE data, the committee voted on the following questions:

  • Does the committee conclude that ADASUVE (loxapine) inhalation powder has been shown to be ef
    '/>"/>

SOURCE Alexza Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. New Company Starts, Bridging the Development Gap in the Discovery of Cancer Drugs
2. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
3. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
4. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
5. Aegerion Pharmaceuticals, Inc. Presents Final Results of Phase II Clinical Trials for AEGR-733 at Drugs Affecting Lipid Metabolism (DALM) 2007 Conference
6. Surface Logix Presents Positive Phase 1 Repeat-Dose Trial Data on SLx-4090 at The 16th International Symposium on Drugs Affecting Lipid Metabolism
7. First High-Res 3-D Structures of Mammalian HSP90 Protein Solved, Key to Better Targets for AIDS, Sepsis, Cancer Drugs
8. Powerful New Efficacy Data in Moderate and Severe Hypertensive Patients Supports FDA Approval of AVALIDE(R) (Irbesartan-Hydrochlorothiazide) as the First Combination Therapy for Initial Use in Patients Likely to Need Multiple Drugs to Achieve Their Blood
9. Micromet Announces the Publication of BiTE Antibody Review in Drugs of the Future
10. NexGenix Pharmaceuticals Presents Data on a Novel Small Molecule Inhibitor of Heat Shock Protein 90 (Hsp90) at the GTCbio Cancer Drugs Research & Development Conference
11. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)...  BioLife Solutions, Inc. (NASDAQ: BLFS ), a leading ... storage and cryopreservation freeze media and ... or the "Company"), announced that the Company is scheduled to ... The Company is scheduled to present at the Conference at ... Grand Hyatt Hotel in New York City ...
(Date:5/22/2015)... The leading companies in the cardiac ... rhythm management device market dominate their competition, according ... Jude Medical, Boston Scientific and Asahi Kasei (with ... The healthcare market research publisher,s report, Cardiac ... a base year, providing forecasts for each year ...
(Date:5/22/2015)... 2015  The U.S. Food and Drug Administration,s ... first biosimilar product approved in the ... in the contract manufacturing organization (CMO) industry, according ... geared to the production of small-molecular drugs and ... The healthcare market research publisher,s report, Biopharmaceutical ...
Breaking Medicine Technology:BioLife Solutions To Present At The 2015 Marcum MicroCap Conference In New York City 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 2Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 3Kalorama: First FDA-Approved Biosimilar Brings Hope for CMO Growth 4
... May 5, 2011 American Regent is conducting a ... following product: Caffeine & Sodium Benzoate Injection, USP, ... # 0517-2502-10, Lot # 0084,  Exp Date  February, 2012 ... 2011 to the User or Consumer Level, is for Lot # ...
... 2011 CareFusion Corp. (NYSE: CFN ), ... for the three and nine months ended March 31, ... "Our business performed well in the quarter, ... margins through a favorable product mix and disciplined expense ...
Cached Medicine Technology:American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 2American Regent Initiates Nationwide Voluntary Recall of Caffeine & Sodium Benzoate Injection, USP 250 mg/mL, 2 mL Single Dose Vial Due to Visible Particulates 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 2CareFusion Reports Third Quarter Rise in Revenue, Earnings 3CareFusion Reports Third Quarter Rise in Revenue, Earnings 4CareFusion Reports Third Quarter Rise in Revenue, Earnings 5CareFusion Reports Third Quarter Rise in Revenue, Earnings 6CareFusion Reports Third Quarter Rise in Revenue, Earnings 7CareFusion Reports Third Quarter Rise in Revenue, Earnings 8CareFusion Reports Third Quarter Rise in Revenue, Earnings 9CareFusion Reports Third Quarter Rise in Revenue, Earnings 10CareFusion Reports Third Quarter Rise in Revenue, Earnings 11CareFusion Reports Third Quarter Rise in Revenue, Earnings 12CareFusion Reports Third Quarter Rise in Revenue, Earnings 13CareFusion Reports Third Quarter Rise in Revenue, Earnings 14
(Date:5/25/2015)... Burke Rehabilitation Hospital will welcome Samuel ... York City, to speak at Burke on Wednesday, June 3. ... Lobby Lecture series, will take place at 4:30 p.m. on ... grandson of Stanford White of McKim, Mead and White, the ... 100 years ago. , “We are thrilled to welcome Samuel ...
(Date:5/24/2015)... Pacific Prime has announced that they have launched the second ... of individual international health insurance. Titled: The Cost of Health Insurance ... health insurance in six top expat destinations, which are also popular ... Kong , Singapore , China , ... UK , Article 2 presents an in-depth look at ...
(Date:5/24/2015)... 24, 2015 Women's Excellence in ... loss. Although it is unclear about the etiology of ... factors such as metabolism, nutritional deficiencies, thyroid abnormalities and ... a comprehensive approach to evaluating the metabolic, nutritional and ... can help patients find a cause for their problem. ...
(Date:5/24/2015)... Clarkston, Metamora, Michigan (PRWEB) May 24, 2015 ... will allow them to take pressure measurements in patients’ ... function. The doctor usually orders it if they have ... bladder (OAB). , Women’s Excellence in Bladder ... problems with unwanted urinary leakage or problems with overall ...
(Date:5/24/2015)... 24, 2015 EnviroLeather™ by LDI, ... Plus” – a classic, rugged leather grain with ... difficult stains, including ink, to be easily removed. ... suitable for corporate, healthcare, hospitality and education environments. ... EnviroLeather’s goal of developing products that are more ...
Breaking Medicine News(10 mins):Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 2Health News:Burke Rehabilitation Hospital Welcomes Architect Samuel White, Descendant of McKim, Mead and White, for Legacy Lobby Lecture 3Health News:Pacific Prime Releases 2nd Article of Cost of Health Insurance Report 2Health News:Women's Excellence Now Treats Menopausal Hair Loss 2Health News:EnviroLeather By LDI Launches "InkGard Plus" - Stain Resistant Faux Leather 2
... of access to medical care a big factor in ... half of the Americans who meet the criteria for ... survey indicates. , "There is a definite gap between ... an internist in the Yale University Robert Wood Johnson ...
... specializing in Medicare supplement insurance plans, says MARS Act could ... access to necessary services. , ... ... news, according to MedicareSupplementPlans.com: Legislation designed to remove Medicare’s annual ...
... Clients Prepare and RespondPHILADELPHIA, April 24 International SOS ... information regarding the swine flu outbreak to members of ... http://urgent.interna t ionalsos.com , ... to frequently asked questions that those in California, Texas ...
... Telemedicine Inc. announces the completion of its transformation from a telemedicine ... (TEMS™) , ... North Chelmsford, MA (PRWEB) April 24, ... transformation to a Telemedicine Encounter Management Systems company. AMD will ...
... allows for remote physician participation in real time ... -- Scottsdale, Ariz.-based GlobalMedia, an innovator ... in the practice of telemedicine, announced today that ... product line, the TransportAV, at the American Telemedicine ...
... United American Healthcare Corporation (Nasdaq: UAHC ... a managed care organization in Tennessee, today announced it ... quarter ended March 31, 2009 on Thursday, May 7, ... a conference call at 4:30 p.m. Eastern time the ...
Cached Medicine News:Health News:Many Who Should Use Statins Don't 2Health News:Many Who Should Use Statins Don't 3Health News:MedicareSupplementPlans.com Says News Legislation Could Affect Physical, Speech Therapy Benefits for Medicare Recipients 2Health News:International SOS Releases Web Site to Educate Public About Swine Flu Outbreak 2Health News:AMD Global Telemedicine Inc. to Unveil New Solutions at ATA 2009 Conference in Las Vegas 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 2Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 3Health News:GlobalMedia Launches Telemedicine Product for Ambulatory and Emergency Care 4Health News:United American Healthcare Corporation to Host Fiscal 2009 Third Quarter Results Conference Call May 7th 2
... Allows Use Through A 1-Millimeter Incision.,Special ... Approach To The Incision.,Cystotome Tips Are ... Initiate And Complete A Circular Tear.,Titanium ... Improved Ergonomic Feel. Ideal For Bi-Manual ...
2.5V Incandescent source, 3X magnification, pocket-sized....
Pocket-sized instrument with 2.5X magnification....
... offer patented Sensomatic® handles that ... up and switch off when ... of light from 2.5V halogen ... of examination area. Used ...
Medicine Products: